Previous reports showed that down-regulation of COX5A significantly decreases COX activity, leading to mitochondrial dysfunction, pulmonary arterial hypertension, lactic academia, hypoglycemia, growth delay, and failure to thrive [18,19]. This evidence concerns the gene COX5A and Failure to thrive.